Personalis Inc PSNL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Are DAN, GPRO, PSNL Obtaining Fair Deals for their Shareholders?
Personalis Reports Third Quarter Results
PSNL Shareholder Notice: Personalis $16.25 per Share Merger Under Investigation on Behalf of Shareholders
PSNL Legal Notice: Personalis Shareholders are Notified to Contact BFA Law About the Ongoing Investigation into the $16.25 per Share Merger
Are PAG, BRBS, PSNL Obtaining Fair Deals for their Shareholders?
Are BWMN, PAG, CCC, PSNL Obtaining Fair Deals for their Shareholders?
PSNL Investor Investigation: Personalis Shareholders Are Alerted to the Pending Investigation into the $16.25 per Share Merger
Are VRNS, DSGR, PSNL Obtaining Fair Deals for their Shareholders?
Trading Information
- Previous Close Price
- $15.88
- Day Range
- $15.90–16.04
- 52-Week Range
- $4.96–18.89
- Bid/Ask
- $15.94 / $16.24
- Shares Outstanding
- 108.40M
- Market Cap
- $1.73B
- Volume/Avg
- 1M / 3M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 20.19
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 260
- Website
- https://www.personalis.com
Valuation
Metric | PSNL |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 8.13 |
Price/Sales | 20.19 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | PSNL |
|---|---|
Quick Ratio | 4.23 |
Current Ratio | 4.53 |
Interest Coverage | −684.21 |
Quick Ratio
PSNL
Profitability
Metric | PSNL |
|---|---|
Return on Assets (Normalized) | −36.47% |
Return on Equity (Normalized) | −48.38% |
Return on Invested Capital (Normalized) | −43.33% |
Return on Assets
PSNL
Diagnostics & Research Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | LOCK|Txq>sgx | LOCK|jH | $266B | |||
| Danaher Corp DHR | LOCK|yD^?@nG | LOCK|@^% | $166B | |||
| IDEXX Laboratories Inc IDXX | LOCK|d>NSlWgF | LOCK|RJ | $55B | |||
| Agilent Technologies Inc A | LOCK|?!Cthv> | LOCK|^tl | $50B | |||
| Waters Corp WAT | LOCK|Mf@&b& | LOCK|&T | $46B | |||
| IQVIA Holdings Inc IQV | LOCK|$##R&qR | LOCK|&&hJ | $45B | |||
| Mettler-Toledo International Inc MTD | LOCK|@v$z!p>% | LOCK|&Sm# | $35B | |||
| Illumina Inc ILMN | LOCK|K!><Y<R | LOCK|R?#? | $32B | |||
| Labcorp Holdings Inc LH | LOCK|^r%?p?> | LOCK|b?&@ | $30B | |||
| Quest Diagnostics Inc DGX | LOCK|YF#w@b | LOCK|R$kW | $28B |
United States